Hidradenitis Suppurativa
📧 Sign up to get email alerts when something new happens for Hidradenitis Suppurativa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Defects of Keratinocytes Function in Dermatologic Patients
An update on a trial investigating defects of keratinocyte function in dermatologic patients, currently recruiting for hidradenitis suppurat…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating sonelokimab for active moderate-to-severe hidradenitis suppurati…
-
FDA approval · 2024-04-30FDA Approved: ABRILADA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for ABRILADA (adalimumab-afzb) from Pfizer Laboratories Div Pfizer Inc, authorizing its use as a…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa [NA]
A completed clinical trial evaluating Nd:YAG laser treatment for hidradenitis suppurativa conducted by Henry Ford Health System. The study i…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Safety and Treatment of Cryoinsufflation in Treatment of Hidradenitis Suppurativa [NA]
This clinical trial update reports on the safety and use of cryoinsufflation for hidradenitis suppurativa, noting that the study has been te…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa [Phase 2]
Phase 2 proof-of-concept trial evaluating the effectiveness of ustekinumab in hidradenitis suppurativa has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-05Clinical Trial Update: Guselkumab for Hidradenitis Suppurativa, a Mode of Action Study. [Phase 2]
Phase 2 clinical trial update evaluating guselkumab for hidradenitis suppurativa focusing on mode of action.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Hidradenitis Suppurativa (HS) Tunneling Wounds [NA]
A completed clinical trial on hidradenitis suppurativa focusing on tunneling wounds has posted results as of 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating safety and efficacy of BDB-001 injections in moderate to severe hidradenitis suppurativa has complete…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) [Phase 2]
Amgen completed a Phase 2 trial (AURORA) evaluating the safety and efficacy of avacopan in moderate-to-severe hidradenitis suppurativa; resu…
-
FDA approval · 2023-12-15FDA Approved: HULIO — Supplemental Application (Biocon Biologics Inc)
The FDA approved a supplemental application for HULIO, Biocon Biologics' biosimilar adalimumab (adalimumab-fkJP).
-
FDA approval · 2023-11-30FDA Approved: ADALIMUMAB — Supplemental Application (CELLTRION USA, Inc.)
The FDA approved a supplemental Biologics License Application for the adalimumab biosimilar ADALIMUMAB-AATY from Celltrion USA, Inc., allowi…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
Phase 2 trial of bermekimab for moderate-to-severe hidradenitis suppurativa was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa [Phase 4]
Phase 4 trial updating dosing for intralesional triamcinolone in hidradenitis suppurativa; study terminated with results posted.
-
FDA approval · 2023-11-03FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approves a supplemental application for HUMIRA (adalimumab) to Cordavis Limited, enabling an additional manufacturing/supply pathway for…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Metformin for the Treatment of Hidradenitis Suppurativa (HS) [Phase 3]
Phase 3 clinical trial update for metformin in hidradenitis suppurativa has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: A Randomized, Controlled Trial Comparing the Use of a Biodegradable Temporizing Matrix to Cadaver Skin in the Reconstruction of Hidradenitis Suppurativa Excisions [Phase 4]
A Phase 4 randomized trial compares a biodegradable temporizing matrix to cadaver skin for reconstructing hidradenitis suppurativa excisions…
-
FDA approval · 2023-09-21FDA Approved: ADALIMUMAB — Supplemental Application (CELLTRION USA, Inc.)
FDA approved a supplemental Biologics License Application for the adalimumab biosimilar ADALIMUMAB-AATY from Celltrion USA, approving its bi…
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) [Phase 2]
Phase 2 trial assessing efficacy and safety of BDB-001 injection in adults with moderate to severe hidradenitis suppurativa has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS) [Phase 3]
A Phase 3 trial evaluating two Secukinumab dosing regimens in adults with moderate-to-severe hidradenitis suppurativa has completed, and res…
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa [Phase 2]
Phase 2 trial evaluating bermekimab in hidradenitis suppurativa has completed with posted results.
-
FDA approval · 2023-07-19FDA Approved: ADALIMUMAB-ADBM — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
The FDA approved a supplemental application for ADALIMUMAB-ADBM, a biosimilar of adalimumab from Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: Clinical Trial to Evaluate Safety and Efficiency of Mesenchymal Stem Cell in Patients With Hidradenitis Suppurativa [Phase 1, Phase 2]
Clinical trial evaluating the safety and efficacy of mesenchymal stem cells in patients with hidradenitis suppurativa (Phase 1/2).
-
FDA approval · 2023-06-30FDA Approved: ADALIMUMAB-ADBM — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
The FDA approved a supplemental application for the adalimumab biosimilar ADALIMUMAB-ADBM from Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa [Phase 2]
Phase 2 trial evaluating PF-06650833, PF-06700841, and PF-06826647 in adults with hidradenitis suppurativa (acne inversa) completed with pos…